Literature DB >> 30824326

Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles.

Daping Yang1, Xi Chen2, Jingjing Wang1, Qi Lou1, Yunwei Lou1, Li Li3, Honglin Wang4, Jiangye Chen5, Meng Wu6, Xinyang Song6, Youcun Qian7.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a severe form of lung fibrosis with a high mortality rate. However, the etiology of IPF remains unknown. Here, we report that alterations in lung microbiota critically promote pulmonary fibrosis pathogenesis. We found that lung microbiota was dysregulated, and the dysregulated microbiota in turn induced production of interleukin-17B (IL-17B) during bleomycin-induced mouse lung fibrosis. Either lung-microbiota depletion or IL-17B deficiency ameliorated the disease progression. IL-17B cooperated with tumor necrosis factor-α to induce expression of neutrophil-recruiting genes and T helper 17 (Th17)-cell-promoting genes. Three pulmonary commensal microbes, which belong to the genera Bacteroides and Prevotella, were identified to promote fibrotic pathogenesis through IL-17R signaling. We further defined that the outer membrane vesicles (OMVs) that were derived from the identified commensal microbes induced IL-17B production through Toll-like receptor-Myd88 adaptor signaling. Together our data demonstrate that specific pulmonary symbiotic commensals can promote lung fibrosis by regulating a profibrotic inflammatory cytokine network.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteroides; Prevotella; bleomycin-induced fibrosis; idiopathic pulmonary fibrosis; interleukin-17B; lung microbiota; outer membrane vesicles

Mesh:

Substances:

Year:  2019        PMID: 30824326     DOI: 10.1016/j.immuni.2019.02.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  47 in total

1.  Orchestration of human macrophage NLRP3 inflammasome activation by Staphylococcus aureus extracellular vesicles.

Authors:  Xiaogang Wang; William J Eagen; Jean C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-27       Impact factor: 11.205

Review 2.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

Review 3.  Impact of the microbiota on solid organ transplant rejection.

Authors:  Martin Sepulveda; Isabella Pirozzolo; Maria-Luisa Alegre
Journal:  Curr Opin Organ Transplant       Date:  2019-12       Impact factor: 2.640

Review 4.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

Review 5.  The impact of lung microbiota dysbiosis on inflammation.

Authors:  Daping Yang; Yingying Xing; Xinyang Song; Youcun Qian
Journal:  Immunology       Date:  2019-11-11       Impact factor: 7.397

Review 6.  Fibrosis: from mechanisms to medicines.

Authors:  Neil C Henderson; Florian Rieder; Thomas A Wynn
Journal:  Nature       Date:  2020-11-25       Impact factor: 49.962

7.  Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles.

Authors:  Tanyalak Parimon; Changfu Yao; David M Habiel; Lingyin Ge; Stephanie A Bora; Rena Brauer; Christopher M Evans; Ting Xie; Felix Alonso-Valenteen; Lali K Medina-Kauwe; Dianhua Jiang; Paul W Noble; Cory M Hogaboam; Nan Deng; Olivier Burgy; Travis J Antes; Melanie Königshoff; Barry R Stripp; Sina A Gharib; Peter Chen
Journal:  JCI Insight       Date:  2019-08-08

Review 8.  Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Authors:  David J Lee; Howard J Lee; Jocelyn R Farmer; Kerry L Reynolds
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

Review 9.  The evolving role of the lung microbiome in pulmonary fibrosis.

Authors:  Jay H Lipinski; Bethany B Moore; David N O'Dwyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 5.464

Review 10.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.